Nurse Practitioner, Family · Norwood, MA
NPI
1134596778
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
4
Medicare group memberships
Hospitals
4
Hospital affiliations
115 Norwood Park S
Norwood, MA, 02062
Phone (781) 349-5181
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
248 services
Medicare patients, 2024
101
Average age 73
Drug cost, 2024
$936K
1,086 prescriptions
Company payments, 2025
$361
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Erin Macneill was code 99214 (office e&m - established), 109 times for 62 patients. In total Erin Macneill billed 248 services in 13 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 109 | 62 | $94.28 | $10K |
| 99214 Office E&M - Established | Facility | 43 | 41 | $62.76 | $2,698 |
| 94010 Pulmonary Function Testing | Facility | 35 | 35 | $5.38 | $188 |
| 99205 Office E&M - New | Office | 26 | 26 | $161.52 | $4,200 |
By year: 2022 $14K for 208 services; 2023 $15K for 215 services; 2024 $18K for 248 services.
Medicare prescription drug claims, 2024
In 2024, the drug Erin Macneill prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 158 prescriptions and refills. In total Erin Macneill wrote 1,086 Medicare prescriptions that cost $936K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 158 | 211 | 33 | $133K |
| Montelukast Sodium Generic | 98 | 217 | 30 | $1,463 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 79 | 98 | 37 | $2,824 |
| Prednisone Generic | 67 | 67 | 38 | $219 |
| Symbicort Budesonide/Formoterol Fumarate | 65 | 101 | 18 | $20K |
| Spiriva Respimat Tiotropium Bromide | 58 | 92 | 18 | $46K |
| Fasenra Pen Benralizumab | 54 | 98 | Under 11 | $305K |
| Azithromycin Generic | 47 | 62 | 27 | $244 |
| Dupixent Pen Dupilumab | 40 | 40 | Under 11 | $142K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 39 | 45 | Under 11 | $27K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 30 | 46 | 15 | $6,563 |
| Fluticasone Propionate Generic | 29 | 71 | 13 | $511 |
| Tezspire Tezepelumab-Ekko | 29 | 34 | Under 11 | $144K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 24 | 30 | Under 11 | $2,446 |
| Xolair Omalizumab | 23 | 23 | Under 11 | $42K |
Brand drugs: 696 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Erin Macneill $361 ($361 in general payments such as food, travel and fees) from 6 companies. The largest payer was Inspire Medical Systems, Inc. with $130.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.